AMA Proposes New Payment Models to CMS

Share this content:
AMA Proposes New Payment Models to CMS
AMA Proposes New Payment Models to CMS

(HealthDay News) -- The American Medical Association (AMA) and other specialty societies have created new care delivery and payment models that they expect to be supported by the Centers for Medicare & Medicaid Services, according to a recent AMA news release.

The AMA has recommended detailed actions CMS should take in developing new specialty payment models, including allowing flexibility; offering risk protection for physicians; and providing timely, accurate data so physicians can benchmark their progress.

RELATED: Practice Management Resource Center

While CMS sought comments on the procedural episodes and complex chronic disease approaches, the AMA suggested that a model designed around uncomplicated chronic disease management could help prevent patients from developing more advanced disease and experiencing acute episodes. 

In addition, the AMA suggested another potential model for specialty-specific, risk-adjusted global payments. This model would allow larger practices or multi-specialty groups to design comprehensive, specialty-specific or condition-specific global payments that would cover all services needed to treat a specific condition managed by that specialty.

"A relatively small number of different types of payment reforms can be developed that will be applicable to a broad range of specialties and the majority of patients within each specialty," the AMA said in its comments to CMS.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs